Digital Maze Therapy Using Sensory Substitution for Neuroplasticity

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current treatments for neurodegenerative diseases like Alzheimer's disease focus on managing symptoms but fail to prevent or slow down disease progression, and there is a lack of effective therapies to enhance neuroplasticity and synaptic connectivity.

Innovation Solution

A computer-implemented method using digital mazes on personal electronic devices that provide sensory modality inputs to navigate, incorporating sensory inhibition, substitution, and integration to improve neuroconnectivity and synaptic connectivity.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If current symptom management treatments are used for neurodegenerative diseases, then patient symptoms can be managed, but disease progression cannot be prevented or slowed and neuroplasticity enhancement is insufficient

Engineering Contradiction:
Improvedisease progression preventionVSAvoidneuroplasticity enhancement efficacy
Core Design Contradiction:
ReliabilityVSProductivity

Solution Approach 1:

The patent replaces traditional pharmacological interventions with a digital therapeutic system that uses sensory modalities (visual, auditory, tactile) delivered through personal electronic devices. This substitution creates a non-invasive mechanism to stimulate neuroplasticity and cognitive functions without relying on chemical drugs, thereby addressing the limitation of current treatments that cannot prevent disease progression.

Inventive Principle:
Principle #28Mechanics substitution (Replace mechanical system)

Solution Approach 2:

The patent introduces digital content and sensory stimuli as intermediaries between the treatment delivery system and the patient's brain. These intermediaries (digital mazes, cognitive tasks, sensory inputs) mediate the therapeutic effect by engaging neural pathways and promoting neuroplasticity, bridging the gap between symptom management and disease modification.

Inventive Principle:
Principle #24Intermediary (Mediator)

2Productivity

If digital therapy platforms are developed to enhance neuroplasticity, then cognitive functions can be improved, but the complexity of personalized treatment protocols increases

Engineering Contradiction:
Improvecognitive function improvementVSAvoidpersonalized treatment protocol complexity
Core Design Contradiction:
ProductivityVSDevice complexity

Solution Approach 1:

The patent creates a universal digital therapy platform that can deliver multiple types of therapeutic interventions (visual tasks, auditory tasks, tactile tasks, cognitive mazes) through a single system. This multi-functional platform serves diverse therapeutic needs without requiring separate complex systems for each intervention type, thereby improving cognitive functions while managing overall system complexity.

Inventive Principle:
Principle #6Universality (Multi-functionality)

Solution Approach 2:

The patent implements dynamic treatment protocols that adapt to individual patient responses and progress. The system can adjust task difficulty, modality selection, and intervention parameters based on real-time performance data, creating personalized treatment paths without requiring manually complex protocol design. This dynamic adaptation enables cognitive improvement while keeping the treatment system manageable.

Inventive Principle:
Principle #15Dynamics

Data Source

PatentUS12579904B2Digital mazes in therapeutics
Publication Date: 2026.03.17 REMEPY HEALTH LTD
  • US12579904B2 patent drawing
  • US12579904B2 patent drawing
  • US12579904B2 patent drawing

AI summary

The presently disclosed subject matter relates to computer-based methods in the field of digital therapeutics by means of a digital maze. The digital mazes utilize: sensory inhibition, sensory substitution, sensory integration, or a combination thereof. Various digital interventions, their related methods in digital therapeutics and systems are disclosed herein.